---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-012519"
form_type: "8-K"
ticker: "MYO"
cik: "0001369290"
company_name: "MYOMO, INC."
filed_at: "2022-07-07T23:59:59+00:00"
generated_at: "2026-06-24T19:16:35.709809+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Myomo pre-announces Q2 revenue $3.4-3.6M, up 10-16% YoY; record pipeline adds

## Summary
- Preliminary Q2 2022 revenue $3.4–$3.6M, up 10–16% vs Q2 2021; all product revenue.
- Added >400 prospective MyoPro patients in Q2, a quarterly record; cost per pipeline add decreased.
- Second JV license fee payment from China partner delayed due to COVID-19 banking/government backlog.
- Participated in CMS public hearing for Benefit Category Determination to reclassify MyoPro as custom-fabricated brace.
- Full Q2 results and conference call scheduled for August 3, 2022.

## SEC filing metadata
- accession: 0000950170-22-012519
- form_type: 8-K
- ticker: MYO
- cik: 0001369290
- company_name: MYOMO, INC.
- filed_at: 2022-07-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1369290/000095017022012519/0000950170-22-012519-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1369290/000095017022012519/myo-20220707.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-012519
- JSON: https://secwatch.observer/filing/0000950170-22-012519.json
- Plain text: https://secwatch.observer/filing/0000950170-22-012519.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.